Baxter’s Homechoice Claria APD System Receives the US FDA’s 510 (k) Clearance for Kidney Failure

November 24, 2020 Auto Bot Clearance, kidney failure, MedTech, receives 0

Shots:

  • Baxter has received the FDA’s clearance for its APD system designed for home use, combining it with Sharesource that aims to help patients with kidney disease manage their care remotely
  • The Homechoice Claria system was cleared for both adults and children. Its interface is available in 38 languages and features step-by-step, voice-activated instructions through an app to guide the user through therapy
  • The clearance follows the recent finalization of the ESRD ETC payment model aims to increase the number of new patients with kidney failure who receive home dialysis and organ transplants. Homechoice Claria with Sharesource will be available in the US in the coming weeks

Click here ­to­ read full press release/ article | Ref: Baxter | Image: BusinessWire

The post Baxter’s Homechoice Claria APD System Receives the US FDA’s 510 (k) Clearance for Kidney Failure first appeared on PharmaShots.